Cargando…
Sodium glucose cotransporter‐2 inhibitor was associated with an improvement in left ventricular systolic function in patients with type 2 diabetes mellitus with impaired left ventricular systolic function
AIMS: Recent studies indicated that sodium glucose cotransporter‐2 inhibitors (SGLT2i) reduced heart failure hospitalization in patients with type 2 diabetes mellitus (T2DM). However, whether SGTL2i can improve left ventricular (LV) systolic and diastolic function remained unclear. This study aimed...
Autores principales: | Chan, Yi‐Hsin, Hsu, Tzyy‐Jer, Wang, Chun‐Li, Kao, Yi‐Wei, Huang, Chien‐Ying, Chu, Pao‐Hsien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524050/ https://www.ncbi.nlm.nih.gov/pubmed/32627380 http://dx.doi.org/10.1002/ehf2.12877 |
Ejemplares similares
-
Left ventricular global systolic function assessment by echocardiography
por: Chengode, Suresh
Publicado: (2016) -
Left Ventricular Diastolic and Systolic Functions in Patients with Hypothyroidism †
por: Tafarshiku, Rina, et al.
Publicado: (2020) -
Left ventricular systolic function in dogs with pulmonic stenosis
por: Trikhun, Ploypanut, et al.
Publicado: (2020) -
Massive Mobile Left Ventricular Thrombus in a Patient With Normal Left Ventricular Systolic Function
por: Papadopoulos, Gregory, et al.
Publicado: (2019) -
The association of C-reactive protein with left ventricular systolic function and left ventricular myocardial fibrosis
por: Ahmed, Mohammed, et al.
Publicado: (2009)